41 results
424B3
BTTX
Better Therapeutics Inc
14 Mar 24
Prospectus supplement
9:37am
at www.sec.gov. Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly
8-K
EX-99.1
BTTX
Better Therapeutics Inc
14 Mar 24
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
9:35am
. Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors
424B3
BTTX
Better Therapeutics Inc
10 Jan 24
Prospectus supplement
7:01am
, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land … , or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture
8-K
EX-10.1
BTTX
Better Therapeutics Inc
8 Jan 24
Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
4:42pm
, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater … , contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating
424B3
f3c5xdadfaht7hezbn
28 Dec 23
Prospectus supplement
9:23pm
8-K
EX-10.1
qog5ak xs4lzbgvk0tf
13 Dec 23
Entry into a Material Definitive Agreement
5:06pm
PRE 14A
3w2q5118fjs w7
6 Oct 23
Preliminary proxy
4:15pm
8-K
EX-10.2
k1s0q64
26 Jul 23
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
5:11pm
8-K
EX-10.1
jmg 0j7hij
26 Jul 23
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
5:11pm
8-K
EX-10.1
mqqmrd9l
11 May 23
Entry into a Material Definitive Agreement
5:23pm